Seguir
Natalija Dedić Plavetić
Natalija Dedić Plavetić
Associate Professor, University of Zagreb, School of Medicine
Dirección de correo verificada de kbc-zagreb.hr
Título
Citado por
Citado por
Año
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—An European consensus statement and expert recommendations
CF Singer, J Balmaña, N Bürki, S Delaloge, ME Filieri, AM Gerdes, ...
European Journal of Cancer 106, 54-60, 2019
442019
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic
D Mauri, K Kamposioras, M Tolia, F Alongi, D Tzachanis, B Petricevic, ...
The Lancet Oncology 21 (6), 759-760, 2020
352020
Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype
A Kulić, ND Plavetić, S Gamulin, J Jakić-Razumović, D Vrbanec, ...
Medical Oncology 33, 1-6, 2016
322016
Fatal outcome of posterior “reversible” encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen
N Dedić Plavetić, Z Rakušić, D Ozretić, L Simetić, AM Krpan, V Bišof
World journal of surgical oncology 12, 1-4, 2014
292014
Prognostic value of proliferation markers expression in breast cancer
N Dedić Plavetić, J Jakić-Razumović, A Kulić, D Vrbanec
Medical oncology 30, 1-13, 2013
262013
Role of HER2 signaling pathway in breast cancer: biology, detection and therapeutical implications
N Dedić Plavetić, A Kulić, D Vrbanec
Periodicum biologorum 114 (4), 505-510, 2012
192012
Breast cancer subtypes and oxidative DNA damage
D Jakovčević, N Dedić Plavetić, D Vrbanec, A Jakovčević, ...
Applied Immunohistochemistry & Molecular Morphology 23 (10), 693-703, 2015
17*2015
Low serum MMP-1 in breast cancer: a negative prognostic factor?
A Kulić, N Dedić Plavetić, J Vrbanec, M Sirotković-Skerlev
Biomarkers 17 (5), 416-421, 2012
172012
Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years)
M Sirotković-Skerlev, ND Plavetić, F Sedlić, SK Kuna, D Vrbanec, B Belev, ...
Cancer Biomarkers 30 (1), 95-104, 2021
132021
Smjernice za genetičko savjetovanje i testiranje na nasljedni rak dojke i jajnika
A Borovečki, M Braš, B Brkljačić, N Canki-Klain, N Dedić Plavetić, ...
Liječnički vjesnik 139 (5-6), 0-0, 2017
122017
HER2 Low breast cancer: a new subtype or a Trojan for cytotoxic drug delivery?
M Popović, T Silovski, M Križić, N Dedić Plavetić
International journal of molecular sciences 24 (9), 8206, 2023
112023
Synthesis of recommendations from 25 countries and 31 oncology societies: how to navigate through Covid-19 labyrinth
K Kamposioras, D Mauri, K Papadimitriou, A Anthoney, N Hindi, ...
Frontiers in oncology 10, 575148, 2020
112020
Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu …
M Barić, A Kulić, M Sirotković-Skerlev, N Dedić Plavetić, M Vidović, ...
Pathology & Oncology Research 21, 589-595, 2015
112015
Behind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients’ survival
D Mauri, D Tzachanis, A Valachis, K Kamposioras, M Tolia, M Dambrosio, ...
J BUON 25 (3), 1277-1280, 2020
102020
SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA–KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak …
N Dedić Plavetić, T Silovski, A Tečić Vuger, M Pavlović, L Vazdar, ...
Liječnički vjesnik 140 (3-4), 0-0, 2018
102018
Prognostic value of ki-67 in breast carcinoma: tissue microarray method versus whole section analysis-potentials and pitfalls
N Dedić Plavetić, J Jakić-Razumović, A Kulić, M Sirotković-Skerlev, ...
Pathology & Oncology Research 21, 315-324, 2015
92015
Smjernice za provođenje dijagnostičkih pretraga prije početka liječenja onkološkog bolesnika–kliničke preporuke hrvatskog društva za internističku onkologiju hlz-a i. dio …
R Šeparović, L Vazdar, A Tečić Vuger, M Pavlović, M Gnjidić, J Prejac, ...
Liječnički vjesnik 140 (3-4), 0-0, 2018
82018
Praćenje onkoloških bolesnika–kliničke preporuke Hrvatskog društva za internističku onkologiju HLZ-a V. dio: melanom, sarkomi, tumori središnjega živčanog sustava, rak pluća …
D Herceg, M Jakopović, N Dedić Plavetić, M Samaržija, B Čučević, ...
Liječnički vjesnik 139 (1-2), 17-23, 2016
72016
THE FIRST WAVE OF THE COVID-19 PANDEMIC AND ITS IMPACT ON THE LEVEL OF DISTRESS IN PATIENTS WITH BREAST CANCER, A MULTICENTRIC STUDY
A Budisavljevic, R Kelemenic-Drazin, N Dedic Plavetic, ...
Psychiatria Danubina 33, 341-349, 2021
62021
Hypoxia in solid tumors: biological responses to hypoxia and implications on therapy and prognosis
D PLAVETIĆ, ND PLAVETIĆ, MB BARIĆ, LB BRADIĆ, ANA Kulić, ...
Periodicum biologorum 116 (4), 361-364, 2014
62014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20